PROVIDENT FINANCIAL SERVICES INC·4

Feb 2, 3:13 PM ET

MARTIN CHRISTOPHER P 4

4 · PROVIDENT FINANCIAL SERVICES INC · Filed Feb 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Provident Financial (PFS) Chairman Christopher Martin Sells 76,327 Shares

What Happened
Christopher P. Martin, Executive Chairman and Director of Provident Financial Services, exercised equity derivatives and immediately sold 76,327 shares on January 30, 2026. The shares were sold in multiple transactions at prices ranging from $21.94 to $22.17 (weighted average $22.05), producing approximately $1,683,010 in proceeds. Footnotes indicate the underlying stock options were fully vested.

Key Details

  • Transaction date: 2026-01-30; Form 4 filed: 2026-02-02 (timely filing).
  • Transaction type: M = exercise/conversion of derivative followed by disposition (shares sold).
  • Shares sold: 76,327; weighted average sale price: $22.05; total proceeds: $1,683,010.
  • Price range: $21.94–$22.17; reporting person can provide per-trade breakdown on request (footnote).
  • Footnotes note a transfer of 26,413 shares from a terminated ESOP into a 401(k) plan; some related transfers/transactions were not required to be reported.
  • Shares owned after the transaction: not disclosed in the provided filing.

Context
This was an exercise of vested options with the resulting shares sold (a cashless or immediate-sale pattern), a common liquidity- or tax-driven action by insiders. Such sales are routine and do not by themselves indicate the insider’s long-term view; purchases are generally a stronger bullish signal.

Insider Transaction Report

Form 4
Period: 2026-01-30
MARTIN CHRISTOPHER P
DirectorExecutive Chairman
Transactions
  • Exercise/Conversion

    Stock Options

    [F3][F4]
    2026-01-30$22.05/sh76,327$1,683,0100 total
    Exercise: $18.70From: 2017-02-24Exp: 2026-02-24Common Stock (76,327 underlying)
Holdings
  • Common Stock

    601,050
  • Common Stock

    [F1]
    (indirect: By 401(k))
    238,014
  • Common Stock

    [F2]
    (indirect: By ESOP)
    0
  • Stock Options

    [F3]
    Exercise: $23.70From: 2023-03-02Exp: 2032-03-02Common Stock (34,353 underlying)
    34,353
  • Stock Options

    [F3]
    Exercise: $20.66From: 2022-03-03Exp: 2031-03-03Common Stock (56,605 underlying)
    56,605
  • Stock Options

    [F3]
    Exercise: $20.62From: 2021-03-03Exp: 2030-03-03Common Stock (107,240 underlying)
    107,240
  • Stock Options

    [F3]
    Exercise: $27.25From: 2020-03-04Exp: 2029-03-04Common Stock (41,685 underlying)
    41,685
  • Stock Options

    [F3]
    Exercise: $25.58From: 2019-03-05Exp: 2028-03-05Common Stock (43,124 underlying)
    43,124
  • Stock Options

    [F3]
    Exercise: $26.31From: 2018-03-07Exp: 2027-03-07Common Stock (42,857 underlying)
    42,857
Footnotes (4)
  • [F1]Reflects transfer of 26,413 shares resulting from termination of ESOP and transfer into 401(k) Plan, and transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F2]Reflects transfer of 26,413 shares resulting from termination of ESOP and transfer into 401(k) Plan.
  • [F3]Stock options have fully vested.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.94 to $22.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
Signature
/s/Chao Huang, Pursuant to Power of Attorney|2026-02-02

Documents

1 file
  • 4
    wk-form4_1770063199.xmlPrimary

    FORM 4